EFPIA - NEWSLETTER

EFPIA Newsletter 03 September 2020

Statements

26 August 2020 26082020 EFPIA statement on COVID-19 vaccine

Developing a compensation system that works for patients, healthcare systems and all those fighting COVID-19

12 August 2020 EU Orphan Regulation evaluation; meeting unmet need and facilitating access

EFPIA strongly believes that the evidence in both the study and SWD support keeping the existing legislation on orphan...

Blogs

02 September 2020 The Innovative Medicines Initiative: a partnering machine that has transformed the biomedical...

A blog post by Dr Pierre Meulien, Executive Director, Innovative Medicines Initiative

02 September 2020 The time they do not have: providing patients rapid access to innovation

Getting patients access to these new life-saving and time-giving therapies is key, because for patients, this is time...

25 August 2020 August is Spinal Muscular Atrophy (SMA) awareness month

#WeWontRest until every patient and caregiver gets an equal opportunity to care, so that people impacted by SMA can...

27 August 2020 #WeWontRest until we improve the lives of people living with SMA and stop their disease progression...

A blog post from Michaela Hrdlickova, Biogen

01 August 2020 World Lung Cancer Day: Mission Not Yet Accomplished

Lung cancer outcomes have improved but there is still a long way to go. We, as leaders from different companies, are...

The Innovative Medicines Initiative (IMI) carries the torch of medical innovation to fight against new and old diseases

#IMICarryTheTorch

The Innovative Medicines Initiative (IMI) has established a neutral platform where teams of bright minds from industry, academia, regulators, NGOs and patients' organisations from all over Europe can join forces to accelerate medical innovation

CARE: A new consortium against COVID-19 supported by the Innovative Medicines Initiative (IMI)

CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19.

Events

18 SEP 2020

Understand diabetes, rethink diabetes, share solutions Virtual event

Are we doing the best we can for the 60 million Europeans living with diabetes?

Learn more →

21 SEP 2020

Every day counts Virtual event

Accelerate access. Beat cancer.

Learn more →

24 SEP 2020

How can the EU establish global leadership through an ambitious trade policy? Virtual event

Join us to debate on what the best way forward for EU Trade policy can be

Learn more →

28 SEP 2020

Neurological diseases: Lessons learnt from COVID and the future of neuroscience Virtual event

EFNA, EFPIA and EBC are delighted to invite you to join this virtual event.

Learn more →

29 SEP 2020

Regulatory Science Forum 2020 Utrecht, The Netherlands

Organised by DIA

Learn more →

26 OCT 2020

NEW DATES - EU Health Summit 2020 Virtual event

The EU Health Coalition is delighted to announce the second edition of the EU Health Summit.

Learn more →

Our latest publications

Free trade agreement with MRA in the best interest of European pharma, says new research 23 July 2020 (News & Events)

New research published today outlines the importance of a free trade agreement with a mutual recognition agreement for...

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶